May 05, 2014 at 10:24 | Source: Moneycontrol.com
The total income of the company declined to Rs 42.57 crore during the first quarter, as compared to Rs 71.83 crore in the same period of previous fiscal.
May 05, 2014 at 10:07 | Source: PTI
The total income of the company declined to Rs. 42.57 crore during the first quarter, as compared to Rs. 71.83 crore in the same period of previous fiscal.
May 05, 2014 at 08:53 | Source: CNBC-TV18
Following are the top 10 stocks to keep a watch on BPCL, Indiabulls Real, ABB, Suzlon, Tata Motors, Ashok Leyland, Sparc, Rel Comm, Future Lifestyle, V-Guard
Feb 28, 2014 at 09:29 | Source: Moneycontrol.com
The key drug which is to be studied for epilepsy is Levetiracetam ER. The estimated peak sales at USD 35-50 million and it may be approved by FY16.
Feb 28, 2014 at 09:18 | Source: CNBC-TV18
Kunal Saraogi, Equityrush advises buying JSW Energy for a target price of Rs 53 and BPCL for a target price of Rs 390.
Feb 28, 2014 at 08:39 | Source: CNBC-TV18
Eicher Motors | IOC | BPCL | iGate | Titan Company | Ramky Infrastructure | United Bank of India | Venus Remedies | Infosys | Sun Pharma Advanced Research | Arvind | VST Industries | Lupin | Power Grid | ITI | Hero Motocorp | Maruti Suzuki | Financial Technologies | MCX | Tech Mahindra and United Spirits are stocks, which are in the news today.
Feb 17, 2014 at 16:49 | Source: Moneycontrol.com
Sparc Systems has reported a standalone sales turnover of Rs 0.01 crore and a net loss of Rs 0.03 crore for the quarter ended Dec '13
Jan 24, 2014 at 08:48 | Source: CNBC-TV18
Ranbaxy Labs | Sesa Sterlite | Hindustan Zinc | MBL Infra | Mastek | GMR Infrastructure | Sun Pharma Advanced Research Company | L&T Finance Holdings | Novartis | Cairn India | Triveni Turbine | Zee Media and Parrys Sugar are stocks, which are in the news today.
Jan 24, 2014 at 08:47 | Source: Moneycontrol.com
Sun Pharma Advanced Research Company (SPARC) announced that its licensee has received an approval from the Drug Controller General of India (DCGI) for Paclitaxel Injection Concentrate for Nanodispersion (PICN), indicated for the treatment of metastatic breast cancer.
Dec 18, 2013 at 09:27 | Source: Moneycontrol.com
Sun Pharma Advanced Research Co. Ltd. (SPARC) announced receipt f a Complete Response Letter from the US FDA on its New Drug Application (NDA) for Venlafaxine Extended-release tablets in 300 mg strength, an anti-depressant product.